Zusammenfassung
Zahlreiche Untersuchungen haben in den vergangenen Jahren gezeigt, dass Valproat in der Behandlung von einigen Subgruppen von Patienten mit bipolaren Störungen der Therapie mit Lithium überlegen ist. Hierzu gehören vor allem Patienten mit dysphorischer Manie oder mit „Rapid-cycling-Verlauf“. Das folgende Kapitel stellt die aktuelle Datenlage zu diesem Thema vor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Akiskal HS (1994) Dysthymic and cyclothymic depressions: Therapeutic considerations. J Clin Psychiatry 55 Suppl: 46–52
Akiskal HS (1996) The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J Clin Psychopharmaco116 Suppl 1: 4S–14S
Akiskal HS, Puzantian VR (1979) Psychotic forms of depression and mania. Psychiatr Clin North Am 2: 419–439
Angst J (1985) Switch from depression to mania. A record study over the decades 1920–1982. Psychopathology 18: 140–154
Bauer MS, Whybrow PC (1990) Rapid cycling affective disorder. Treatment of refractory rapid cycling with high dose levothyroxine: a preliminary study. Arch Gen Psychiatry 47: 435–440
Bourgeois ML, Hantouche EG, Akiskal HS (1997) The EPIMAN and EPIDEP French studies on bipolarity. J Bipolar Disorder 1: 13–19
Bourgeois ML, Verdoux H (1997) Le risque suicidaire dans les troubles bipolaires. Encephale 23 Spec No 1: 35–41
Bourgeois ML, Verdoux H, Mainard CH (1995) Dysphoric mania and mixed states. Encephale 21 Spec No 6: 21–32
Bowden CL (1995) Predictors of response to divalproex and lithium. J Clin Psychiatry 56 Suppl 3: 25–30
Bowden CL, Brugger AM, Swann AC et al. for the Depakote Mania Study Group (1994) Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 271: 918–924
Brady KT, Sonne SC (1995) The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 56 Suppl 3: 19–24
Bräunig P (1990) Switch processes and rapid cycling in bipolar affective disorders, cycloid psychoses and non-systematic schizophrenia. Psychopathology 23: 291–302
Bumke O (1936) Lehrbuch der Geisteskrankheiten. Bergmann, München
Calabrese JR, Delucchi GA (1989) Phenomenology of rapid cycling manic depression and its treatment with valproate. J Clin Psychiatry 5o Suppl: 30–34
Calabrese JR, Delucchi GA (1990) Spectrum of efficacy of valproate in 55 patients with rapid cycling bipolar disorder. Am J Psychiatry 147: 431–434
Calabrese JR, Woyshville MJ (1995a) Lithium therapy: Limitations and alternatives in the treat
Calabrese JR, Woyshville MJ (1995b) A medication algorithm for treatment of bipolar rapid cycling? J Clin Psychiatry 56 Suppl 3: 11–18
Calabrese JR, Fatemi SH, Kujawa M, Woyshville MJ (1996) Predictors of response to mood stabilizers. J Clin Psychopharmacol 16 (2 Suppl 1): 24S–31S
Calabrese JR, Markovitz PJ, Kimmel SE, Wagner SC (1992) Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmaco112 (1 Suppl): 53S–56S
Calabrese JR, Rapport DJ, Kimmel SE, Reece B, Woyshville MJ (1993) Rapid cycling bipolar dis-order and its treatment with valproate. Can J Psychiatry 38 Suppl 2: 57–61
Cassidy F, Forest K, Murry E, Carroll BJ (1998) A factor analysis of the signs and symptoms of mania. Arch Gen Psychiatry 55: 27–32
Chou JC (1991) Recent advances in the treatment of acute mania. J Clin Psychopharmacol 11:3–21
Clothier J, Swann AC, Freeman T (1992) Dysphoric mania. J Clin Psychopharmacol 12(1 Suppl): 13S–16S
Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C (1991) Does lithium reduce the mortality of recurrent mood disorders? J Affective Disord 23: 1–7
Dilsaver SC, Swann AC, Shoaib AM, Bowers TC (1993) The manic syndrome: Factors which may predict a patient’s response to lithium, carbamazepine and valproate. J Psychiatry Neurosci 18: 61–66
Dunner DL, Fieve RR (1974) Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 30: 229–233
Emrich HM, Dose M, von Zerssen D (1985) The use of sodium valproate, carbamazepine and oxcarbamazepine in patients with affective disorders. J Affective Disord 8: 243–250
Erfurth A, Grunze H (1998) New perspectives in the treatment of acute mania: A single case report. Prog Neuropsychopharmacol Biol Psychiatry 22: 1053–1059
Erfurth A, Walden J, Grunze H (1998) Lamotrigine in the treatment of schizoaffective disorder. Neuropsychobiology 38: 204–205
Faedda GL, Baldessarini RJ, Tohen M, Strakowski SM, Waternaux C (1991) Episode sequence in bipolar disorder and response to lithium treatment. Am J Psychiatry 148: 1237–1239
Fatemi SH, Rapport DJ, Calabrese JR, Thuras P (1997) Lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 58: 522–527
Gnam W, Flint AJ (1993) New onset rapid cycling bipolar disorder in an 87 year old woman. Can J Psychiatry 38: 324–326
Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L (1998) Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients. J Clin Psychiatry 59: 151–158
Goodman FK, Jamison KR (1990) Manic-depressive illness. Oxford University Press, New York
Hayes SG (1994) Acetazolamide in bipolar affective disorders. Ann Clin Psychiatry 6: 91–98
Herridge PL, Pope HG Jr (1985) Treatment of bulimia and rapid-cycling bipolar disorder with sodium valproate: a case report. J Clin Psychopharmacol 5: 229–230
Hopkins HS, Gelenberg AJ (1994) Treatment of bipolar disorder: How far have we come? Psychopharmacol Bull 30: 27–38
Jacobsen FM (1993) Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome. J Clin Psychiatry 54: 229–234
Joyce PR (1988) Carbamazepine in rapid cycling bipolar affective disorder. Int Clin Psychopharmacol 3: 123–129
Keck PE Jr, McElroy SL, Bennett JA (1996a) Health-economic implications of the onset of action of antimanic agents. J Clin Psychiatry 57 Suppl 13: 13–18
Keck PE Jr, Nabulsi AA, Taylor JL, Henke CJ, Chmiel JJ, Stanton SP, Bennett JA (1996b) A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar I disorder. J Clin Psychiatry 57: 213–222
Ketter TA, Pazzaglia PJ, Post RM (1992) Synergy of carbamazepine and valproic acid in affective illness: Case report and review of the literature. J Clin Psychopharmaco112: 276–281
Krüger S, Bräunig P, Young LT (1996) Biological treatment of rapid-cycling bipolar disorder. Pharmacopsychiatry 29: 167–175
Kukopulos A, Caliari B, Tundo A, Minnai G, Floris G, Reginaldi D, Tondo L (1983) Rapid cyclers, temperament and antidepressants. Compr Psychiatry 24: 249–258
Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L (1980) Course of the manic-depressive cycle and changes caused by treatment. Pharmacopsychiatr Neuropharmaco113:156–167
Kusumakar V, Yatham LN (1997) Lamotrigine treatment of rapid cycling bipolar disorder. Am J Psychiatry 154: 1171–1172
Kusumakar V, Yatham LN, Haslam DRS, Parikh SV, Matte R, Silverstone PH, Sharma V (1997) Treatment of mania, mixed state, and rapid cycling. Can J Psychiatry 42 Suppl 2: 79S–86S
Leibenluft E (1997) Issues in the treatment of women with bipolar illness. J Clin Psychiatry 58 Suppl 15: 5–11
Lepkifker E, Iancu I, Dannon P, Ziv R, Kotler M (1995) Valproic acid in ultra-rapid cycling: A case report. Clin Neuropharmacol 18: 72–75
Licht RW (1998) Drug treatment of mania: A critical review. Acta Psychiatr Scand 97: 387–397
Manna V (1991) Therapeutic effects of the treatment with lithium salts and/or calcium antagonists in patients with rapid polar inversion. Minerva Medica 82: 757–763
Maj M, Magliano L, Pirozzi R (1994) Validity of rapid cycling as a course specifier for bipolar disorder. Am J Psychiatry 151: 1015–1019
McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI, Faedda GL, Swann AC (1992) Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 149: 1633–1644
McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI, Morris D (1991) Correlates of antimanic response to valproate. Psychopharmacol Bull 27: 127–133
Okuma T (1993) Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology 27: 138–145
Pariser SF (1993) Women and mood disorders. Menarche to menopause. Ann Clin Psychiatry 5: 249–254
Pazzaglia PJ, Post RM, Ketter TA, George MS, Marangell LB (1993) Preliminary controlled trial Of nimodipine in ultra-rapid cycling affective dysregulation. Psychiatry Res 49: 257–272
Perugi G, Akiskal HS, Micheli C et al. (1997) Clinical subtypes of bipolar mixed states: validating a broader European definition in 143 cases. J Affect Disord 43: 169–18o
Post RM, Ketter TA, Pazzaglia PJ et al.(1996) Rational polypharmacy in the bipolar affective disorders. Epilepsy Res Supp111:153–18o
Post RM, Rubinow DR, Uhde TW, Roy-Byrne PP, Linnoila M, Rosoff A, Cowdry R (1989) Dys-phoric mania. Clinical and biological correlates. Arch Gen Psychiatry 46: 353–358
Puzynski S, Klosiewicz L (1984) Valproic acid amide in the treatment of affective and schizo-affective disorders. J Affect Disord 6: 115–121
Retzow A, Emrich HM (1998) Therapie bipolarer affektiver Erkrankungen mit Valproat. Psychiatr Praxis 25:163–171
Schaff MR, Fawcett J, Zajecka JM (1993) Divalproex sodium in the treatment of refractory affective disorders. J Clin Psychiatry 54: 380–384
Schneider AL, Wilcox CS (1998) Divalproate augmentation in lithium-resistant rapid cycling mania in four geriatric patients. J Affect Disord 47: 201–205
Sechter D (1996) Place des thymoregulateurs dans le traitement des troubles bipolaires. Encephale 22: 65–68
Sharma V, Persad E (1992) Augmentation of valproate with lithium in a case of rapid cycling affective disorder. Can J Psychiatry 37: 584–585
Sharma V, Persad E, Mazmanian D, Karunaratne K (1993) Treatment of rapid cycling bipolardisorder with combination therapy of valproate and lithium. Can J Psychiatry 38: 137–139
Small JG, Klapper MH, Kellams JJ, Miller MJ, Milstein V, Sharpley PH, Small IF (1988) ECT corn-pared with lithium in the management of manic states. Arch Gen Psychiatry 45: 727–732
Spitzer RL, Endicott J, Robbins E (1975) Research Diagnostic Criteria (RDC) for a selected group of functional disorders. 2nd edn. New York State Psychiatric Institute, New York/NY
Solomon DA, Keitner GI, Miller IW, Shea MT, Keller MB (1995) Course of illness and mainten-ance treatments for patients with bipolar disorder. J Clin Psychiatry 56: 5–13
Sovner R (1991) Divalproex-responsive rapid cycling bipolar disorder in a patient with Down’s syndrome: implications for the Down’s syndrome-mania hypothesis. J Ment Defic Res 35: 171–173
Steele M, Fisman S (1997) Bipolar disorder in children and adolescents: Current challenges. Can J Psychiatry 42: 632–636
Swann AC, Stokes PE, Casper R et al. (1992) Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. Acta Psychiatr Scand 85: 270–274
Swann AC, Bowden CL, Morris D et al. (1997) Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 54: 37–42
Walden J, Heßlinger B (1995) Bedeutung alter and neuer Antiepileptika in der Behandlung psychischer Erkrankungen. Fortschr Neurol Psychiatr 63: 320–335
Wehr TA, Goodwin FK (1987) Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 144: 1403–1411
Wehr TA, Sack DA, Rosenthal NE, Cowdry RW (1998) Rapid cycling affective disorder: Contri-buting factors and treatment responses in 51 patients. Am J Psychiatry 145:179–184
Weygandt W (1899) Über die Mischzustände des manisch-depressiven Irreseins. München
Whittier MC, West SA, Galli VB, Raute NJ (1995)Valproic acid for dysphoric mania in a mental-ly retarded adolescent. J Clin Psychiatry 56: 590–591
Worthington JJ 3rd, Pollack MH (1996) Treatment of dysphoric mania with nefazodone. Am J Psychiatry 153: 732–733
Wroblewski BA, Joseph AB, Kupfer J, Kalliel K (1997) Effectiveness of valproic acid on destruc-tive and aggressive behaviours in patients with acquired brain injury. Brain Inj 11: 37–47
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Erfurth, A., Grunze, H., Walden, J. (2002). Valproinsäure zur Behandlung von „rapid cycling“ und dysphorischer Manie. In: Krämer, G., Walden, J. (eds) Valproinsäure. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56329-4_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-56329-4_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63068-2
Online ISBN: 978-3-642-56329-4
eBook Packages: Springer Book Archive